Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any Fuchs' endothelial dystrophy in which the cause of the disease is a mutation in the SLC4A11 gene.
Features include always present findings: Corneal guttata. 3 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 3 | Clouding of the cornea (corneal dystrophy), Visual impairment, Corneal guttata |
Age of onset: later in life.
SLC4A11 function has not been fully characterized.
Corneal dystrophy, Fuchs endothelial, 4 is associated with mutations in the SLC4A11 gene on chromosome 20.
Genetic testing for SLC4A11 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 1 always present feature.
No clinical trials have been registered for corneal dystrophy, Fuchs endothelial, 4.
21 publications have been identified in PubMed for corneal dystrophy, Fuchs endothelial, 4. Research spans Basic Science / Preclinical (52%), Review / Meta-Analysis (19%), and Clinical Trial Publication (14%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 11 | 52% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 3:04 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Research summaries
4 |
19% |
Clinical study results | 3 | 14% |
New treatment approaches | 2 | 10% |
Disease patterns and progression | 1 | 5% |
Kotova ES (2026). [PMID: 42115719](https://pubmed.ncbi.nlm.nih.gov/42115719/). *Sci Rep*. [Basic Science / Preclinical]
Landi E (2026). [PMID: 41285302](https://pubmed.ncbi.nlm.nih.gov/41285302/). *Progress in retinal and eye research*. [Review / Meta-Analysis]
Zhang BN (2026). [PMID: 41850243](https://pubmed.ncbi.nlm.nih.gov/41850243/). *Cell reports. Medicine*. [Gene Therapy / Novel Therapeutics]
Zhang W (2026). [PMID: 41896991](https://pubmed.ncbi.nlm.nih.gov/41896991/). *Biology of sex differences*. [Epidemiology / Natural History]
Zhao X (2026). [PMID: 41575439](https://pubmed.ncbi.nlm.nih.gov/41575439/). *Investigative ophthalmology & visual science*. [Basic Science / Preclinical]
Nayak D (2026). [PMID: 42061480](https://pubmed.ncbi.nlm.nih.gov/42061480/). *Free Radic Biol Med*. [Basic Science / Preclinical]
Nakagawa T (2025). [PMID: 40048186](https://pubmed.ncbi.nlm.nih.gov/40048186/). *Investigative ophthalmology & visual science*. [Basic Science / Preclinical]
Kovaleva PA (2025). [PMID: 40563515](https://pubmed.ncbi.nlm.nih.gov/40563515/). *Biomolecules*. [Review / Meta-Analysis]
Tomioka Y (2025). [PMID: 40502296](https://pubmed.ncbi.nlm.nih.gov/40502296/). *Ophthalmology science*. [Clinical Trial Publication]
Ito S (2025). [PMID: 40197778](https://pubmed.ncbi.nlm.nih.gov/40197778/). *Investigative ophthalmology & visual science*. [Basic Science / Preclinical]